IRIS Accounts Production v26.1.10.61 00349867 director 1.4.25 31.3.26 31.3.26 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh003498672025-03-31003498672026-03-31003498672025-04-012026-03-31003498672024-03-31003498672024-04-012025-03-31003498672025-03-3100349867ns15:EnglandWales2025-04-012026-03-3100349867ns14:PoundSterling2025-04-012026-03-3100349867ns10:Director12025-04-012026-03-3100349867ns10:PrivateLimitedCompanyLtd2025-04-012026-03-3100349867ns10:SmallEntities2025-04-012026-03-3100349867ns10:AuditExempt-NoAccountantsReport2025-04-012026-03-3100349867ns10:SmallCompaniesRegimeForDirectorsReport2025-04-012026-03-3100349867ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-3100349867ns10:FullAccounts2025-04-012026-03-3100349867ns10:RegisteredOffice2025-04-012026-03-3100349867ns5:CurrentFinancialInstruments2026-03-3100349867ns5:CurrentFinancialInstruments2025-03-3100349867ns5:ShareCapital2026-03-3100349867ns5:ShareCapital2025-03-3100349867ns5:RetainedEarningsAccumulatedLosses2026-03-3100349867ns5:RetainedEarningsAccumulatedLosses2025-03-3100349867ns5:PlantMachinery2025-03-3100349867ns5:MotorVehicles2025-03-3100349867ns5:PlantMachinery2025-04-012026-03-3100349867ns5:MotorVehicles2025-04-012026-03-3100349867ns5:PlantMachinery2026-03-3100349867ns5:MotorVehicles2026-03-3100349867ns5:PlantMachinery2025-03-3100349867ns5:MotorVehicles2025-03-3100349867ns5:WithinOneYearns5:CurrentFinancialInstruments2026-03-3100349867ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3100349867ns5:WithinOneYear2026-03-3100349867ns5:WithinOneYear2025-03-3100349867ns5:BetweenOneFiveYears2026-03-3100349867ns5:BetweenOneFiveYears2025-03-3100349867ns5:AllPeriods2026-03-3100349867ns5:AllPeriods2025-03-31
REGISTERED NUMBER: 00349867 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026

FOR

LBS (SERVING BIOTECHNOLOGY) LTD.

LBS (SERVING BIOTECHNOLOGY) LTD. (REGISTERED NUMBER: 00349867)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


LBS (SERVING BIOTECHNOLOGY) LTD.

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2026







DIRECTOR: A Iglesias





REGISTERED OFFICE: Second Floor Ridgeland House
15 Carfax
Horsham
West Sussex
RH12 1ER





REGISTERED NUMBER: 00349867 (England and Wales)





ACCOUNTANTS: Galloways Accounting (Horsham) Limited
Ridgeland House
15 Carfax
Horsham
West Sussex
RH12 1ER

LBS (SERVING BIOTECHNOLOGY) LTD. (REGISTERED NUMBER: 00349867)

BALANCE SHEET
31 MARCH 2026

2026 2025
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 52,392 52,804

CURRENT ASSETS
Stocks 326,851 315,507
Debtors 5 887,231 546,675
Cash at bank 366,442 508,056
1,580,524 1,370,238
CREDITORS
Amounts falling due within one year 6 388,889 485,500
NET CURRENT ASSETS 1,191,635 884,738
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,244,027

937,542

PROVISIONS FOR LIABILITIES 58 -
NET ASSETS 1,243,969 937,542

CAPITAL AND RESERVES
Called up share capital 1,000 1,000
Retained earnings 1,242,969 936,542
1,243,969 937,542

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 11 August 2026 and were signed by:





A Iglesias - Director


LBS (SERVING BIOTECHNOLOGY) LTD. (REGISTERED NUMBER: 00349867)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026


1. STATUTORY INFORMATION

Lbs (Serving Biotechnology) Ltd. is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents amounts receivable for the supply of specialised feeds and associated products net of VAT and trade discounts. Income is recognised upon despatch to customer.

Tangible fixed assets
Tangible assets are stated at cost (or deemed cost) less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful
life.

Plant and machinery- 33.3% straight line
Motor vehicles- 25% on reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Financial instruments
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in administrative expenses.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


LBS (SERVING BIOTECHNOLOGY) LTD. (REGISTERED NUMBER: 00349867)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2026


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

Hire purchase and leasing commitments
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

Pension costs and other post-retirement benefits
The company participates in a group personal pension plan, the amount charged to the profit and loss account in respect of pension costs and other post retirement benefits is the contributions payable in the year. Differences between contributions payable and contributions actually paid are shown as either other creditors or other debtors in the balance sheet.

Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2025 - 6 ) .

LBS (SERVING BIOTECHNOLOGY) LTD. (REGISTERED NUMBER: 00349867)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2026


4. TANGIBLE FIXED ASSETS
Plant and Motor
machinery vehicles Totals
£    £    £   
COST
At 1 April 2025 109,832 41,695 151,527
Additions 14,825 - 14,825
At 31 March 2026 124,657 41,695 166,352
DEPRECIATION
At 1 April 2025 80,481 18,242 98,723
Charge for year 9,374 5,863 15,237
At 31 March 2026 89,855 24,105 113,960
NET BOOK VALUE
At 31 March 2026 34,802 17,590 52,392
At 31 March 2025 29,351 23,453 52,804

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade debtors 405,821 324,709
Amounts owed by group undertakings 403,823 -
Other debtors 77,587 221,966
887,231 546,675

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade creditors 168,422 240,084
Amounts owed to group undertakings 12,765 12,765
Taxation and social security 175,009 203,412
Other creditors 32,693 29,239
388,889 485,500

7. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2026 2025
£    £   
Within one year 98,000 98,000
Between one and five years 122,500 220,500
220,500 318,500